SCHEMBL2709628

SCHEMBL2709628

COc1ccc(-c2c3ccccc3c(-c3c(F)c(F)c(OC)c(F)c3F)c3cccc(F)c23)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 1/20 0.40
SYK P43405 1/20 0.39
ABCG2 Q9UNQ0 2/20 0.36
MAOB P27338 2/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
ENPP1 P22413 1/20 0.36
RELA Q04206 3/20 0.35
NPC1 O15118 2/20 0.35
TP53 P04637 2/20 0.35
MAPT P10636 2/20 0.35
NFKB1 P19838 2/20 0.35
RAB9A P51151 2/20 0.35
NFKB2 Q00653 2/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
CA1 P00915 1/20 0.35
CA2 P00918 1/20 0.35
NFE2L2 Q16236 1/20 0.35
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
ALDH1A1 P00352 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2711128 0.93 ACHE (0.43) ACHESYKMAOBL3MBTL1ENPP1
SCHEMBL2728452 0.92 ACHE (0.37) ACHESYKABCG2MAOBL3MBTL1
SCHEMBL2725932 0.91 ACHE (0.36) ACHESYKABCG2MAOBL3MBTL1
SCHEMBL2728449 0.91 CYP1A2 (0.42) ACHEABCG2SMN1; SMN2ALDH1A1CYP1A2
SCHEMBL2725730 0.89 ACHE (0.42) ACHESYKABCG2MAOBL3MBTL1
SCHEMBL2726193 0.88 ACHE (0.41) ACHESYKMAOBL3MBTL1ENPP1
SCHEMBL2709659 0.87 ALDH1A1 (0.39) NPC1MAPTRAB9ASMN1; SMN2NFE2L2
SCHEMBL2710059 0.87 ACHE (0.50) ACHEABCG2MAOBL3MBTL1ENPP1
SCHEMBL2710023 0.87 ACHE (0.39) ACHESYKABCG2MAOBL3MBTL1
SCHEMBL2710301 0.86 ENPP1 (0.41) ACHESYKMAOBL3MBTL1ENPP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2445987-B1 BLUE/VIOLET DIPHENYLANTHRACENE CHEMILUMINESCENT FLUORESCERS CYALUME TECH INC (US) 2018-05-02 EP disclosed
EP-2445987-B1 BLUE/VIOLET DIPHENYLANTHRACENE CHEMILUMINESCENT FLUORESCERS CYALUME TECH INC (US) 2018-05-02 EP disclosed
US-8257620-B2 Blue/violet diphenylanthracene chemiluminescent fluorescers CYALUME TECHNOLOGIES, INC. (US) 2012-09-04 US disclosed
US-8257620-B2 Blue/violet diphenylanthracene chemiluminescent fluorescers CYALUME TECHNOLOGIES, INC. (US) 2012-09-04 US disclosed
EP-2445987-A1 BLUE/VIOLET DIPHENYLANTHRACENE CHEMILUMINESCENT FLUORESCERS Cyalume Technologies, Inc (US) 2012-05-02 EP disclosed
US-20100327240-A1 Blue/violet diphenylanthracene chemiluminescent fluorescers CYALUME TECHNOLOGIES, INC. 2010-12-30 US disclosed
US-20100327240-A1 Blue/violet diphenylanthracene chemiluminescent fluorescers CYALUME TECHNOLOGIES, INC. 2010-12-30 US disclosed
WO-2010151654-A1 BLUE/VIOLET DIPHENYLANTHRACENE CHEMILUMINESCENT FLUORESCERS CYALUME TECHNOLOGIES, INC. (US) 2010-12-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100327240-A1 Blue/violet diphenylanthracene chemiluminescent fluorescers CYP2F1, FLAD1, AFF1 ACHE 187/4885SYK 2951/4885ABCG2 288/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.